Across the world researchers are focused upon finding a drug treatment for the Coronavirus Disease-2019 (SARS-CoV-2). Logically, much of the focus is repurposing approved drugs, followed by those that are in drug development pipeline. Repurposing drugs is a much quicker endeavor than discovering new ones since their chemical optimization, toxicology profiling, clinical trials and bulk manufacturing are already in place . Several research groups have already proposed possible candidates for testing . The results of this testing could provide a spectrum of outcomes -ranging from a compound that show high promise for use in patient treatment to very little activity. However, hindering some our understanding will be the lack of three-dimensional (3D) knowledge of the drugs' structures and their conformations.